BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20560705)

  • 21. Green light for the cell cycle.
    Inzé D
    EMBO J; 2005 Feb; 24(4):657-62. PubMed ID: 15678103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer therapy: targeting cell cycle regulators.
    Johansson M; Persson JL
    Anticancer Agents Med Chem; 2008 Oct; 8(7):723-31. PubMed ID: 18855574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting cyclin-dependent kinases in gastrointestinal cancer therapy.
    Zhang J; Su G; Lin Y; Meng W; Lai JKL; Qiao L; Li X; Xie X
    Discov Med; 2019 Jan; 27(146):27-36. PubMed ID: 30721649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescent protein biosensor for probing CDK/cyclin activity in vitro and in living cells.
    Van TN; Pellerano M; Lykaso S; Morris MC
    Chembiochem; 2014 Oct; 15(15):2298-305. PubMed ID: 25209885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human.
    Lee YM; Sicinski P
    Cell Cycle; 2006 Sep; 5(18):2110-4. PubMed ID: 16969111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoprecipitation of Cdk-Cyclin Complexes for Determination of Kinase Activity.
    Gallastegui E; Bachs O
    Methods Mol Biol; 2016; 1336():1-8. PubMed ID: 26231703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted interactomics reveals a complex core cell cycle machinery in Arabidopsis thaliana.
    Van Leene J; Hollunder J; Eeckhout D; Persiau G; Van De Slijke E; Stals H; Van Isterdael G; Verkest A; Neirynck S; Buffel Y; De Bodt S; Maere S; Laukens K; Pharazyn A; Ferreira PC; Eloy N; Renne C; Meyer C; Faure JD; Steinbrenner J; Beynon J; Larkin JC; Van de Peer Y; Hilson P; Kuiper M; De Veylder L; Van Onckelen H; Inzé D; Witters E; De Jaeger G
    Mol Syst Biol; 2010 Aug; 6():397. PubMed ID: 20706207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin-dependent kinase modulators and cancer therapy.
    Gallorini M; Cataldi A; di Giacomo V
    BioDrugs; 2012 Dec; 26(6):377-91. PubMed ID: 22928661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A high-throughput bimolecular fluorescence complementation protein-protein interaction screen identifies functional Arabidopsis CDKA/B-CYCD4/5 complexes.
    Boruc J; Inzé D; Russinova E
    Plant Signal Behav; 2010 Oct; 5(10):1276-81. PubMed ID: 20861687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.
    Vermeulen K; Van Bockstaele DR; Berneman ZN
    Cell Prolif; 2003 Jun; 36(3):131-49. PubMed ID: 12814430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.
    Zabihi M; Lotfi R; Yousefi AM; Bashash D
    J Cancer Res Clin Oncol; 2023 Apr; 149(4):1585-1606. PubMed ID: 35781526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell cycle control as a basis for cancer drug development (Review).
    McDonald ER; El-Deiry WS
    Int J Oncol; 2000 May; 16(5):871-86. PubMed ID: 10762622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.
    MacLachlan TK; Sang N; Giordano A
    Crit Rev Eukaryot Gene Expr; 1995; 5(2):127-56. PubMed ID: 8845581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural insights into the functional diversity of the CDK-cyclin family.
    Wood DJ; Endicott JA
    Open Biol; 2018 Sep; 8(9):. PubMed ID: 30185601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complexes of D-type cyclins with CDKs during maize germination.
    Godínez-Palma SK; García E; Sánchez Mde L; Rosas F; Vázquez-Ramos JM
    J Exp Bot; 2013 Dec; 64(18):5661-71. PubMed ID: 24127516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Research on cyclin-dependent kinase inhibitors: state of the art and perspective].
    Zuo MX; Chen XG
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):321-4. PubMed ID: 17892123
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclins, Cyclin-Dependent Kinases, and Cyclin-Dependent Kinase Inhibitors in the Mouse Nervous System.
    Grison A; Atanasoski S
    Mol Neurobiol; 2020 Jul; 57(7):3206-3218. PubMed ID: 32506380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell Cycle-Related Clinical Applications.
    Khan MGM; Wang Y
    Methods Mol Biol; 2022; 2579():35-46. PubMed ID: 36045196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer.
    Javed A; Yarmohammadi M; Korkmaz KS; Rubio-Tomás T
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDKs and cyclins in transition(s).
    Fisher RP
    Curr Opin Genet Dev; 1997 Feb; 7(1):32-8. PubMed ID: 9024639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.